Trevi Therapeutics (TRVI) Prepaid Assets (2018 - 2026)
Trevi Therapeutics' (TRVI) quarterly Prepaid Assets came in at $2.1 million in Q1 2026, up 154.44% year-on-year from $834000.0 in Q1 2025, and up 68.01% quarter-over-quarter from $1.3 million in Q4 2025.
Trevi Therapeutics (TRVI) Prepaid Assets (2018 - 2026) Analysis & Trends
Trevi Therapeutics' Prepaid Assets history runs 9 years deep, the most recent figure standing at $2.1 million for Q1 2026.
- On a quarterly basis, Prepaid Assets rose 154.44% year-over-year to $2.1 million in Q1 2026; TTM through Mar 2026 was $2.1 million, a 154.44% increase from a year earlier, with the FY2025 full-year figure at $1.3 million, up 34.5% from the prior year.
- Prepaid Assets improved to $2.1 million in Q1 2026 per TRVI's latest filing, from $1.3 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $4.0 million in Q3 2023 and bottomed at $477000.0 in Q1 2022.
- The 5-year median for Prepaid Assets is $1.3 million (2025), against an average of $1.4 million.
- Across the five-year window, Prepaid Assets surged 237.74% in 2023 and sank 70.88% in 2024, its largest moves.
- Year by year, Prepaid Assets stood at $795000.0 in 2022, then gained by 20.13% to $955000.0 in 2023, then fell by 1.68% to $939000.0 in 2024, then jumped by 34.5% to $1.3 million in 2025, then soared by 68.01% to $2.1 million in 2026.
- Per Business Quant, the three latest TRVI Prepaid Assets figures stand at $2.1 million (Q1 2026), $1.3 million (Q4 2025), and $2.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Trevi Therapeutics | 2.54 Bn | 2.54 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.12 Mn |
| Dec 31, 2025 | 1.26 Mn |
| Sep 30, 2025 | 2.00 Mn |
| Jun 30, 2025 | 1.77 Mn |
| Mar 31, 2025 | 834,000.00 |
| Dec 31, 2024 | 939,000.00 |
| Sep 30, 2024 | 1.18 Mn |
| Jun 30, 2024 | 830,000.00 |
| Mar 31, 2024 | 721,000.00 |
| Dec 31, 2023 | 955,000.00 |
| Sep 30, 2023 | 4.04 Mn |
| Jun 30, 2023 | 2.08 Mn |
| Mar 31, 2023 | 1.61 Mn |
| Dec 31, 2022 | 795,000.00 |
| Sep 30, 2022 | 1.29 Mn |
| Jun 30, 2022 | 1.65 Mn |
| Mar 31, 2022 | 477,000.00 |
| Dec 31, 2021 | 241,000.00 |
| Sep 30, 2021 | 1.39 Mn |
| Jun 30, 2021 | 1.44 Mn |